Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States

Autor: Qi, Cynthia Z., Bollu, Vamsi, Yang, Hongbo, Dalal, Anand, Zhang, Su, Zhang, Jie
Zdroj: In Clinical Therapeutics August 2021 43(8):1300-1319
Databáze: ScienceDirect